Chapel Hill, NC, United States of America

Agnes Dubey

This inventor holds 1 USPTO granted patent. Top assignee: Research, Incorporated. Active years: 1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Agnes Dubey. Retrieved from https://idiyas.com/inventor/agnes-dubey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1985

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Agnes Dubey: Innovator in Antihyperlipidemic Compounds

Introduction

Agnes Dubey is a prominent inventor based in Chapel Hill, NC (US). She has made significant contributions to the field of pharmacology, particularly in the development of novel compounds aimed at lowering serum lipid levels in mammals.

Latest Patents

Agnes holds a patent for "Antihyperlipidemic N-benzoylsulfamates, N-benzylsulfamates." This invention relates to novel N-benzoylsulfamates, N-benzylsulfamates, and benzylsulfonamides, along with pharmacologically acceptable salts thereof. The patent outlines a method for lowering serum levels in mammals through the administration of these compounds, as well as the pharmaceutical compositions that contain them. She has 1 patent to her name.

Career Highlights

Agnes Dubey is associated with Research, Incorporated, where she has been able to apply her innovative ideas in a collaborative environment. Her work has been instrumental in advancing the understanding and treatment of hyperlipidemia.

Collaborations

Some of her notable coworkers include Steven D Wyrick and Iris H Hall, who have contributed to her research endeavors.

Conclusion

Agnes Dubey's work in the field of antihyperlipidemic compounds showcases her dedication to innovation and her impact on pharmacological research. Her contributions continue to influence the development of effective treatments for lipid-related health issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…